- Category: Business
Business
TearOptix secures funding for presbyopia MF lens tech
Company is developing a tear-and-blink-responsive contact lens technology utilizing tear film dynamics to work with the eye’s natural physiology.Business
iOR Partners launches MD-OD surgery partnership model
First-of-its-kind collaboration is designed to create a streamlined continuum of care for all patients, pivoting to a primarily cash-based system.Business
Leadership watch: New appointments at EOE, OWL, and EyeCool
Leadership changes are underway in the eyecare space—and we’ve got the latest.Business
Newton acquires Founders Optical Lab
Independent optical lab offers ECPs a curated selection of lens designs manufactured in-house from top brands such as Sequel, Neurolens, and others.Business
Eyes On Eyecare accelerates growth with new leadership appointment
Leading eyecare digital media and education platform welcomes Rachel Krug as vice president of Sales.Business
LambdaVision raises $7M to advance space-based artificial retina
Biotech is using space and microgravity to produce its protein-based artificial retina, designed to restore vision in retinal degenerative diseased patients.Business
AOAExcel endorses VisionHQ's in-office patient membership plans
Platform offers optometric practices in-house, customizable membership and subscription plans in lieu of traditional vision insurance for patients.Business
DefEYE and Celularity partner to advance ophthalmic biologics portfolios
Collaboration features a multi-million dollar investment in DefEYE as well as an exclusive sublicense of Celularity’s BIOVANCE amnion-derived ocular allografts.Business
Smartlens raises $5.2 million to advance miLens FDA clearance and launch
Financing to support the ongoing advancement and FDA clearance process of the miLens, an electronics-free contact lens technology.Business
Lilly to purchase Adverum Biotechnologies
With a Q4 closing date in mind, acquisition supports ongoing clinical trials and development activities for Ixo-vec, a one-time IVT gene therapy injection to treat wet AMD.Business
Ciliatech to open US subsidiary supporting clinical advancement of novel glaucoma device
Upcoming clinical trials to study the Intercil Uveal Spacer, a cilioscleral interpositioning device that reestablishes the natural uveoscleral outflow.Business
Topcon invests in Sanro Health
Latest strategic investment involves the Sanro Optimizer, which integrates EMR and imaging data to rapidly identify eligible participants for clinical trials.Business
Leadership update: ImprimisRx gets new CEO, BioTissue forms MAB
Leadership changes are underway in the eyecare space—and we’ve got the latest.Business
EssilorLuxottica purchases RetinAI
Ikarian subsidiary is the developer of the FDA-cleared Discovery platform, an AI-based imaging data management system for diagnosing and monitoring ophthalmic disease progression.Business
Topcon officially debuts the Institute for Digital Health
Oculomics company features an AI-based analytics platform designed to provide fast and secure access to real-world and clinical trial datasets.Business
Topcon purchases Toku, Inc
Acquisition supports ongoing Healthcare from the Eye initiative with a portfolio of AI-based diagnostic and retinal imaging technology.Business
Leadership watch: KALA BIO names new CEO, Aurion Biotech promotes execs
Aurion makes its move ahead of initiating a phase 3 trial in early 2026 for its allogeneic cell therapy, under evaluation for corneal endothelial disease.Business
Verséa Ophthalmics relaunches as DefEYE Inc
Ophthalmic biologics company makes official debut with the exclusive U.S. commercial rights to the BIOVANCE franchise of decellularized biologics.Business
Harrow to purchase Melt Pharmaceuticals
Key draw is the company’s patented oral tablet formulated for a sublingual delivery to provide rapid sedation and analgesia ahead of cataract surgery.Business